XTANDI QUICK START+® Program
The XTANDI QUICK START+® Program provides a one-time, 14-day supply of XTANDI® (enzalutamide) at no cost to new patients who experience a delay in insurance coverage.
- Patient eligibility for the QuickStart+ Program includes:
- Be new to XTANDI therapy
- Have experienced an insurance-related access delay
- Have been prescribed XTANDI for an FDA-approved indication
- Allow patients to start their XTANDI treatment while XTANDI Support Solutions®a or a network specialty pharmacy works with the patient's insurer to resolve coverage issues
- Offers overnight shipping directly to the patient
a XTANDI Support Solutions is a component of Astellas Pharma Support SolutionsSM.
QUICK START+® is a registered trademark of Astellas US LLC.